期刊文献+

心力衰竭中心室肌细胞的离子通道重构与电活动的稳态调节 被引量:3

Remodeling and homeostasis of ion channels in ventricular myocytes in heart failure
下载PDF
导出
摘要 心力衰竭是多种心血管疾病的最终结局。心力衰竭时存在心脏器官水平的结构重构和细胞、离子通道分子水平的心电重构。心脏的离子通道重构最初是在病理状态下维持心功能的适应性反应,但持续存在的病理状态导致的重构本身也可以引起疾病的发生,与心力衰竭中心律失常的发生密切相关。心力衰竭时心室肌细胞多种离子通道的表达和功能发生变化,如IK1、Ito、IKs、ICa-L、IK、INaL、INa+/Ca2+等,导致心室肌细胞的静息电位和动作电位的各期均发生从细微到显著的变化,存在离子通道的重构与心肌细胞电活动的稳态调节。从整体上逆转离子通道重构,以所有离子通道的稳态调节为目标进行治疗,可能是改善心力衰竭时心电重构的关键。 Heart failure (HF) is the ifnal ending of a variety of cardiovascular diseases. There is not only the structural remodeling in heart but also electrical remodeling in the ion channels. Remodeling of the ion channels, which is adaptive response to preserve cardiac function under pathological stress initially, leads to dysfunction itself if the stress is maintained and it is closely related to arrhythmias in HF. Many ion channels of ventricular myocytes change their expressions and functions in HF, such as IK1, Ito, IKs, ICa-L, IK, INaL, INa+/Ca2+, and so on. The resting potential and every period of action potential have their remodeling and homeostasis regulation of ion channels in ventricular myocytes. It provides us a new perspective that reversing the remodeling of ion channels as a whole and regulate the homeostasis of all ion channels is the key to improve the electrical remodeling in HF.
出处 《中国医学前沿杂志(电子版)》 2013年第9期30-35,共6页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 国家自然科学基金(30830051)
关键词 心力衰竭 离子通道 稳态调节 心律失常 Heart failure Ion channels Homeostasis Arrhythmia
  • 相关文献

参考文献48

  • 1Sartiani L,Stillitano F,Cerbai E. Electrophysiologic changes in heart failure:focus on pacemaker channels[J].{H}Canadian Journal of Physiology and Pharmacology,2009,(02):84-90.
  • 2Nass RD,Aiba T,Tomaselli GF. Mechanisms of disease:ion channel remodeling in the failing ventricle[J].{H}CARDIOVASCULAR MEDICINE,2008,(04):196-207.
  • 3De Mello WC,Cherry RC,Manivannan S. Electrophysiologic and morphologic abnormalities in the failing heart:effect of enalapril on the electrical properties[J].{H}Journal of Cardiac failure,1997,(01):53-61.
  • 4Wakisaka Y,Niwano S,Niwano H. Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure[J].{H}Cardiovascular Research,2004,(04):689-699.
  • 5Nattel S,Maguy A,Le Bouter S. Arrhythmogenic ion-channel remodeling in the heart:heart failure,myocardial infarction,and atrial fibrillation[J].{H}Physiological Reviews,2007,(02):425-456.
  • 6Rosati B,McKinnon D. Regulation of ion channel expre-ssion[J].{H}CIRCULATION RESEARCH,2004,(07):874-883.
  • 7MacLachlan MC,Sundnes J,Skavhaug O. A linear system of partial differential equations modeling the resting potential of a heart with regional ischemia[J].{H}Mathematical Biosciences,2007,(01):238-252.
  • 8Chilton L,Ohya S,Freed D. K+ currents regulate the resting membrane potential,proliferation,and contractile responses in ventricular ifbroblasts and myoifbroblasts[J].{H}American Journal of Physiology Heart and Circulatory Physiology,2005,(06):H2931-H2939.
  • 9Salle L,Kharche S,Zhang H. Mechanisms underlying adaptation of action potential duration by pacing rate in rat myocytes[J].{H}Progress in Biophysics and Molecular Biology,2008,(1-3):305-320.
  • 10Fernandez-Velasco M,Ruiz-Hurtado G,Delgado C. I K1 and I f in ventricular myocytes isolated from control and hypertrophied rat hearts[J].{H}Pflugers Archives,2006,(02):146-154.

二级参考文献18

  • 1Michael G,Xiao L,Qi XY,et al.Remodeling of cardiac repolarization:how homeostatic responses can lead to arrhythmogenesis[J].Cardiovasc Res,2009,81 (3):491-499.
  • 2Nattel S,Maguy A,Le Bouter S,et al.Arrhythmogenic ion-channel remodeling in the heart:heart failure,myocardial infarction,and atrial fibrillation[J].Physiol Rev,2007,87 (2):425-456.
  • 3Zicha S,Tsuji Y,Shiroshita TA,et al.Beta-blockers as antiarrhythmic agents[J].Handb Exp Pharmacol,2006,6(171):235-266.
  • 4Den Ruijter HM,Berecki G,Verkerk AO,et al.Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure[J].Circulation,2008,117 (4):536-544.
  • 5Murgatroyd F,Camm AJ.Atrial arrhythmias[J].Lancet,1993,341(8856):1317-1322.
  • 6Kaab S,Nuss HB,Chiamvimonvat N,et al.Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure[J].Circ Res,1996,78 (2):262-273.
  • 7Verkerk AO,Wilders R,Coronel R,et al.Ionic remodeling of sinoatrial node cells by heart failure[J].Circulation,2003,108 (6):760-766.
  • 8Hesse M,Kondo CS,Clark RB,et al.Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a[J].Cardiovasc Res,2007,75 (3):498-509.
  • 9Nattel S,Li D,Yue L.Basic mechanisms of atrial fibrillation:very new insights into very old ideas[J].Annu Rev Physiol,2000,62:51-77.
  • 10Li D,Fareh S,Leung TK,et al.Promotion of atrial fibrillation by heart failure in dogs:atrial remodeling of a different sort[J].Circulation,1999,100(1):87-95.

共引文献13

同被引文献38

  • 1戚艳超,徐明.心肌细胞超微结构改变与心力衰竭[J].中国医学前沿杂志(电子版),2013,5(4):27-30. 被引量:5
  • 2王燕,李勇,范维琥.心力衰竭与促炎症细胞因子的关系[J].国外医学(心血管疾病分册),2005,32(4):222-224. 被引量:2
  • 3刘兵,杨杰孚.心房颤动与冠心病[J].中国医刊,2006,41(4):27-29. 被引量:5
  • 4Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC(HFA) and endorsed by the European Society of Intensive Care Medicine(ESICM)[J]. Eur J Heart Fail, 2008, 10(10):933-989.
  • 5Bonilla IM, Sridhar A, Nishijima Y, et al. Differential effects of the peroxynitrite donor, SIN-I, on atrial and ventrieular myocyte electrophysiology[ J]. J Cardiovasc Pharmacol, 2013, 61 ( 5 ):401-407.
  • 6He Y,Si D, Yang C, et al. The effects of amlodipine and S(-)- amlodipine on vascular endothelial function in patients with hypertensi[J]. Am J Hypertens, 2014, 27(1):27-31.
  • 7Cleland JG, Pennell DJ, Ray SG, et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure(CHRISTMAS trial):randomised controlled trial[J]. Lancet, 2003, 362(9377):14-21.
  • 8Cruz MA, Whitelock J, Dong JF. Evaluation of ADAMTS13 activity in plasma using recombinant von willebrand factor A2 dominanpoly peptide as substrate[J]. Thromb Haemost, 2003, 90(6): 1204-1209.
  • 9Shimokawa H, Aarhus LL, Vanhoutte PM. Porcine coronary arteries with regenerated endotheliurn have a reduced endothelium- dependent responsiveness to aggregating platelets and serotonin[J]. Circ Res, 1987, 61(2):256-270.
  • 10Uemura T, Kaikita K, Yamabe H, et al. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation[J]. Thromb Res, 2009, 124(1):28-32.

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部